AMPH vs LIN · P/E 12, rev $732.0M vs P/E 34, rev $33.99B
Amphastar P (AMPH) versus Linde plc Ordinary Shares (LIN) — a side-by-side from cached financials, not a winner call.
Amphastar P (AMPH) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Linde plc Ordinary Shares (LIN) is a specialty chemicals company listed on US.
Latest reported AMPH revenue for 2024-12-31 was $732.0M. Net income was $159.5M. Revenue was up 13.6% from 2023-12-31 to 2024-12-31. AMPH currently screens at market cap $880.1M and trailing P/E 12.0.
Latest reported LIN revenue for 2025-12-31 was $33.99B. Net income was $6.90B. Revenue was up 3.0% from 2024-12-31 to 2025-12-31. LIN currently screens at market cap $223.87B and trailing P/E 34.5.
AMPH currently screens at market cap $880.1M and trailing P/E 12.0. LIN currently screens at market cap $223.87B and trailing P/E 34.5.
Not investment advice. Open the AMPH and LIN stock pages for the full models.
Not investment advice.